Who is sponsoring NCT05483088?

NCT05483088 is sponsored by Astute Medical, Inc..

What drugs are being tested in NCT05483088?

Interventions in NCT05483088: Urine collection for NEPHROCLEAR CCL14 Test.

What condition does NCT05483088 study?

NCT05483088 studies Acute Kidney Injury.

Is NCT05483088 still recruiting?

NCT05483088 is currently completed. Last updated 26 October 2023.

Last reviewed 2023-10-26 · How we verify

NCT05483088

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Urine Sample Processing Study

Completed Last updated 26 October 2023

What this trial tests

trial testing Urine collection for NEPHROCLEAR CCL14 Test in Acute Kidney Injury in 110 participants. Completed in 31 July 2023.

Timeline

12 November 2021

Primary endpoint
31 July 2023

31 July 2023

Quick facts

Lead sponsor	Astute Medical, Inc.
Status	Completed
Study type	OBSERVATIONAL
Enrollment	110
Start date	12 November 2021
Primary completion	31 July 2023
Estimated completion	31 July 2023
Sites	1 location across United States

Drugs / interventions tested

Urine collection for NEPHROCLEAR CCL14 Test

Conditions studied

Acute Kidney Injury — all drugs for Acute Kidney Injury →

Sponsor

Astute Medical, Inc.

Who can join

21 and older, any sex, with Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of the study is to collect and process urine samples from Intensive Care Unit (ICU) subjects with moderate to severe (Stage 2 or 3) acute kidney injury (AKI) for use in assessing the effects of urine sample freezing and various storage conditions on NEPHROCLEAR™ CCL14 Test results. This study is observational and will have no impact on the medical management of the subject.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Acute Kidney Injury

Currently open trials in the same condition.

NCT07273838 — Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome · Phase 2 · recruiting
NCT07262320 — Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America · recruiting
NCT07351149 — Postoperative Acute Kidney Injury in Children Undergoing Major Non-cardiac Surgery · recruiting
NCT07215702 — A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kid · Phase 2 · recruiting
NCT06654193 — Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05483088 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Astute Medical, Inc.
Last refreshed: 26 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05483088.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing